Incidence of tuberculosis in the United States among HIV-infected persons

Annals of Internal Medicine

Volumn 126, Issue 2, 1997, Pages 123-132

  Markowitz, Norman ^a   Hansen, Nellie I ^b   Hopewell, Philip C ^c   Glassroth, Jeffrey ^d   Kvale, Paul A ^a   Mangura, Bonita T ^e   Wilcosky, Timothy C ^b   Wallace, Jeanne M ^f   Rosen, Mark J ^g   Lee Reichman, B ^e  

^a Henry Ford Health System Division of Infectious Diseases   (United States)

^b RTI INTERNATIONAL   (United States)

^c SAN FRANCISCO GENERAL HOSPITAL   (United States)

^d DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^e University of Medicine and Dentistry of New Jersey   (United States)

^f OLIVE VIEW UCLA MEDICAL CENTER   (United States)

^g BETH ISRAEL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUBERCULIN; VIRUS ANTIGEN;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MOUSE; PRIORITY JOURNAL; RISK FACTOR; TUBERCULIN TEST; TUBERCULOSIS; UNITED STATES;

EID: 0031035020     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-126-2-199701150-00005     Document Type: Article

References (39)

1. Transmission of multidrug-resistant tuberculosis from an HIV-positive client in a residential substance-abuse treatment facility-Michigan. MMWR Morb Mortal Wkly Rep. 1991 ; 40: 129-31.
2. Nosocomial transmission of multidrug-resistant tuberculosis among HIVinfected persons-Florida and New York, 1988-1991. MMWR Morb Mortal Wkly Rep. 1991; 40: 585-91.
3. Daley CL, Small PM. Schecter GF. Schoolnik GK, McAdam RA, Jacobs WR Jr, et al. An outbreak of tuberculosis with accelerated progression among persons infected with the human immunodeficiency virus. An analysis using restriction-fragment-length polymorphisms. N Engl J Med. 1992; 326: 231-5.
4. Edlin BR, Tokars Jl. Grieco MH, Crawford JT. Williams J, Sordillo EM, et al. An outbreak of multidrug-resistant tuberculosis among hospitalized patients with the acquired immunodeficiency syndrome. N Engl J Med. 1992; 326: 1514-21.
5. Tuberculosis morbidity-United States. 1995. MMWR Morb Mortal Wkly Rep. 1996: 45: 366-70.
6. Allen S, Batungwanayo J, Kerlikowske K, Ljfson AR. Wolf W, Granich R, et al. Two-year inddence of tuberculosis in cohorts of HIV-infected and-uninfected urban Rwandan women. Am Rev Respir Dis. 1992; 146: 1439-44.
7. Selwyn PA, Sckell BM. Alcabes P. Friedland GH. Klein RS, Schoenbaum EE. High risk of active tuberculosis in HlV-infected drug users with cutaneous anergy. JAMA. 1992; 268: 504-9.
8. Guelar A, Gatell JM, Verdejo J, Podzamczer D, Lozano L, Aznar E, et al. A prospective study of the risk of tuberculosis among HlV-infected patients. AIDS. 1993; 7: 1345-9.
9. Moreno S, Baraia-Etxaburo J, Bouza E, Parras F, Perez-Tascon M, Miralles P, et al. Risk for developing tuberculosis among anergic patients infected with HIV. Ann Intern Med. 1993; 119: 194-8.
10. Pape. JW, Jean SS, Ho JL. Hafner A, Johnson WD Jr. Effect of isoniazid prophylaxis on incidence of active tuberculosis and progression of HIV infection. Lancet. 1993; 342: 268-72.
11. Melnick SU Sherer R, Louis TA, Hillman D, Rodriguez EM, Lackman C. et al. Survival and disease progression according to gender of patients with HIV infection. The Terry Beim Community Programs for Clinical Research on AIDS. JAMA. 1994; 272: 1915-21.
12. Graham NM, Conn S, Galai N. Astemborski J. Nelson KE, Vlahov D. Incidence of mycobacterial infection and disease in HIV+ and HIV- IDUs [Abstract]. Int Conf AIDS. 1993; 9: 328.
13. Antonucci G, Girardi E, Raviglione MC Ippolito G. Risk factors for tuberculosis in HlV-infected persons. A prospective cohort study. The Gruppo Italiano di Studio Tubercolosi e AIDS (GISTA). JAMA. 1995; 274: 143-8.
14. Dupon M, Texier-Maugein J, Leroy V, Sentilhes A, Pelfegrin JL, Morlat P, et al. Tuberculosis and HIV infection: a cohort study of incidence and susceptibility to antituberculous drugs, Bordeaux. 1985-1993. Groupe d'Epidemiologie Clinique du SIDA en Aquitaine. AIDS. 1995; 9: 577-83.
15. Expanded tuberculosis surveillance and tuberculosis morbidity-United States, 1993. MMWR Morb Mortal Wkly Rep. 1994; 43: 361-6.
16. Cantwell MF, Snider DE Jr, Cauthen GM, Onorato IM. Epidemiology of tuberculosis in the United States, 1985 through 1992. JAMA. 1994; 272: 535-9.
17. Design of a prospective study of the pulmonary complications of human immunodeficiency virus infection. The Pulmonary Complications of HIV Infection Study Group. J Clin Epidemiol. 1993; 46: 497-507.
18. Markowitz N, Hansen NI, Wilcosky TC Hopewell PC Glassroth J, Kvale PA, et al. Tuberculin and anergy testing in HIV-seropositive and HIV-seronegative persons. Ann Intern Med. 1993; 119: 185-93.
19. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome. Council of State and Territorial Epidemiologists; AIDS Program, Center for Infectious Diseases. MMWR Morb Mortal Wkly Rep. 1987; 36(Suppl 1): 1S-15S.
20. American Thoracic Society. Diagnostic standards and classification of tuberculosis. Am Rev Respir Dis. 1990; 142: 725-35.
21. Rothman KJ. Modern Epidemiology. Boston: Little, Brown; 1986: 155, 172, 196, 213.
22. Kahn HA, Sempos CT. Statistical Methods in Epidemiology. New York: Oxford Univ Pr; 1989: 219.
23. Graham NM, Nelson KE, Solomon L, Bonds M, Rizzo RT, Scavotto J, et al. Prevalence of tuberculin positivity and skin test anergy in HIV-1-seropositive and -seronegative intravenous drug users. JAMA. 1992; 267: 369-73.
24. Purified protein derivative (PPD)-tuberculin anergy and HIV infection: guidelines for anergy testing and management of anergic persons at risk of tuberculosis. MMWR Morb Mortal Wkly Rep. 1991; 40: 27-32.
25. Blatt SP, Hendrix CW, Butzin CA, Freeman TM, Ward WW, Hensley RE, et al. Delayed-type hypersensitivity skin testing predicts progression to AIDS in HlV-infected patients. Ann Intern Med. 1993; 119: 177-84.
26. Dolan MJ. Cleric! M, Blatt SP, Hendrix CW, Melcher GP, Boswell RN, et al. In vitro T cell function, delayed-type hypersensitivity skin testing, and CD4+ T cell subset phenotyping independently predict survival time in patients infected with human immunodeficiency virus. J Infect Dis. 1995; 172: 79-87.
27. Di Perri G, Crucian! M, Danz! MC Luzzati R. De Checchi G, Malena M. et al. Nosocomial epidemic of active tuberculosis among HlV-infected patients. Lancet. 1989; 2: 1502-4.
28. Small PM, Shafer RW, Hopewell PC Singh SP, Murphy MJ, Desmond E, et al. Exogenous reinfection with multidrug-resistant Mycobacterium tuberculosis in patients with advanced HIV infection. N Engl J Med. 1993; 328: 1137-44.
29. Small PM, Hopewell PC Singh SP, Paz A, Parsonnet J, Ruston DC et al. The epidemiology of tuberculosis in San Francisco. A population-based study using conventional and molecular methods. N Engl J Med. 1994; 330: 1703-9.
30. Alland D. Kalkut GE, Moss AR, McAdam RA, Hahn JA, Bosworth W, et al. Transmission of tuberculosis in New York City. An analysis by DNA fingerprinting and conventional epidemiologic methods. N Engl J Med. 1994; 330: 1710-6.
31. Dwyer B, Jackson K, Raios K. Sievers A, Wilshire E, ROSS B. DNA restriction fragment analysis to define an extended cluster of tuberculosis in homeless men and their associates. J Infect Dis. 1993; 167: 490-4.
32. Kornbluth RS, McCutchan JA. Skin test responses as predictors of tuberculous infection and of progression in HlV-infected persons [Editorial]. Ann Intern Med. 1993; 119: 241-3.
33. Prevention and control of tuberculosis in U.S. communities with at-risk mi-nority populations. Recommendations of the Advisory Council for the Elimination of Tuberculosis. MMWR Morb Mortal Wkly Rep. 1992; 41: 1-11.
34. Coultas DB, Gong H Jr, Grad R. Handler A. McCurdy SA, Player R, et al. Respiratory diseases in minorities of the United States. Am J Respir Crit Care Med. 1994; 149(3 Pt 2): 593-31.
35. HIV prevalence estimates and AIDS case projections for the United States: report based upon a workshop. MMWR Morb Mortal Wkly Rep. 1990; 39: 1-31.
36. Tuberculosis morbidity-United States, 1992. MMWR Morb Mortal Wkly Rep. 1993: 42: 696-7, 703-4.
37. Onorato I, McCombs S. Morgan WM, McCray E. HIV infection in patients attending tuberculosis clinics. United States, 1988-1992 [Abstract]. Program and abstracts, 33rd International Conference on Antimicrobial Agents and Chemotherapy. Washington, DC: American Society for Microbiology; 1993: 1363.
38. Comstock GW. Epidemiology of tuberculosis. Am Rev Respir Dis. 1982; 125(3 Pt2): 8-15.
39. Reider HL, Cauthen GM, Comstock GW, Snyder DE Jr. Epidemiology of tuberculosis in the United States. Epidemiol Rev. 1989; 11: 79-98.